In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lyothyronine Drug Master File in Korea (Lyothyronine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lyothyronine. The MFDS reviews the Lyothyronine KDMF as part of the drug registration process and uses the information provided in the Lyothyronine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lyothyronine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lyothyronine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lyothyronine suppliers with KDMF on PharmaCompass.